A new trading day began on Tuesday, with Insmed Inc (NASDAQ: INSM) stock price up 2.55% from the previous day of trading, before settling in for the closing price of $158.28. INSM’s price has ranged from $60.40 to $160.62 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -13.12% over the past five years. Meanwhile, its annual earnings per share averaged 0.35%. With a float of $207.27 million, this company’s outstanding shares have now reached $211.11 million.
Insmed Inc (INSM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 1.94%, while institutional ownership is 99.32%. The most recent insider transaction that took place on Sep 12 ’25, was worth 11,129,927. In this transaction Chief People Strategy Officer of this company sold 76,520 shares at a rate of $145.45, taking the stock ownership to the 36,461 shares. Before that another transaction happened on Sep 12 ’25, when Company’s Director sold 10,000 for $145.39, making the entire transaction worth $1,453,900. This insider now owns 262,675 shares in total.
Insmed Inc (INSM) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.27 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 57.56% during the next five years compared to -13.12% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Here are Insmed Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 86.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.70, a number that is poised to hit -1.32 in the next quarter and is forecasted to reach -3.55 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Insmed Inc (NASDAQ: INSM) saw its 5-day average volume 2.23 million, a negative change from its year-to-date volume of 2.72 million. As of the previous 9 days, the stock’s Stochastic %D was 95.51%.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 99.88%, which indicates a significant increase from 99.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.46 in the past 14 days, which was higher than the 3.46 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $134.11, while its 200-day Moving Average is $92.89. Nevertheless, the first resistance level for the watch stands at $164.22 in the near term. At $166.11, the stock is likely to face the second major resistance level. The third major resistance level sits at $169.79. If the price goes on to break the first support level at $158.65, it is likely to go to the next support level at $154.97. The third support level lies at $153.08 if the price breaches the second support level.
Insmed Inc (NASDAQ: INSM) Key Stats
With a market capitalization of 34.31 billion, the company has a total of 211,375K Shares Outstanding. Currently, annual sales are 363,710 K while annual income is -913,770 K. The company’s previous quarter sales were 107,420 K while its latest quarter income was -321,690 K.
